Forbes.com: Waters profit falls
“Weakness in the company’s mass spectrometry business and slowing demand for some of its products from large pharmaceutical customers in the United States and Europe are hurting results.”
Mass spectrometry websites, social media, journal feeds, and other links and items of interest to the mass spectrometry community.